Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Director/PDMR Shareholding

13 Jun 2016 17:18

RNS Number : 0594B
Allied Minds PLC
13 June 2016
 

 

 

FOR RELEASE ON 13 JUNE 2016

Allied Minds plc (the "Company" or the "Group")

 

Director / PDMR Shareholding

 

Allied Minds plc (LSE: ALM), a diversified holding company focused on venture creation within the life science and technology sectors, announces that it received notification from Marc Eichenberger, Chief Operating Officer, a person discharging managerial responsibility ("PDMR"), regarding the sale of the Company's ordinary shares of one pence each ("Ordinary Shares").

 

The Company was notified that, on 07 June 2016, Mr. Eichenberger sold 100,000 Ordinary Shares at a price of 338.0 pence per share, and on 10 June 2016, Mr. Eichenberger sold 84,506 Ordinary Shares at a price of 351.2202 pence per share.

 

As a result of the above transactions, Mr. Eichenberger's total remaining interests in the Company's Ordinary Shares are the following: (i) 1,382,218 Ordinary Shares, (ii) 3,105,498 options over Ordinary Shares issued under the Allied Minds 2008 Stock Option/Issuance Plan, and (iii) 1,044,264 Restricted Share Units issued under the Allied Minds 2014 Long Term Incentive Plan.

This announcement relates to transactions notified in accordance with Disclosure and Transparency Rule ("DTR") 3.1.2R and is given in fulfilment of the obligation under DTR 3.1.4(1)(a).

About Allied Minds

 

Allied Minds (LSE: ALM) is a diversified holding company focused on venture creation within the life science and technology sectors. With unparalleled access to hundreds of university and federal labs across the U.S., Allied Minds forms, funds, and operates a portfolio of companies to generate long-term value for its investors and stakeholders. Based in Boston, with offices in Los Angeles and New York, Allied Minds supports its businesses with capital, central management, and shared services. For more information, please visit www.alliedminds.com.

 

For further information, please contact:

Allied Minds plc +1 (617) 419-1800

Michael S. Turner, Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHGGUQGQUPQGQW
Date   Source Headline
9th Oct 20147:00 amRNSSubsidiary Spin Transfer Technologies Raises $70 M
7th Oct 20147:00 amRNSAllied Minds Launches Novare Pharmaceuticals
3rd Oct 20147:00 amRNSABLS Appoints Satish Jindal
2nd Sep 20145:12 pmRNSHolding(s) in Company
28th Aug 20147:00 amRNSAllied Minds Announces Half-Yearly Results
28th Aug 20147:00 amRNSHalf Yearly Report
27th Aug 20147:00 amRNSFormation of Whitewood Encryption Systems, Inc.
4th Aug 20147:00 amRNSAllied Minds and BMS Form New Enterprise
24th Jul 20143:18 pmRNSDirector/PDMR Shareholding
21st Jul 20147:00 amRNSEnd of Stabilisation Notice
21st Jul 20147:00 amRNSPartial Exercise of Over-allotment Option
25th Jun 20148:04 amRNSAdmission to Trading on the London Stock Exchange
20th Jun 20144:59 pmRNSPublication of Prospectus
20th Jun 20147:01 amRNSStabilisation Notice
20th Jun 20147:00 amRNSInitial Public Offering

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.